All Access Articles |
- Analyzing Viatris (VTRS) as a Contrarian Stock Choice | 2025-03-19 | PHARMACEUTICAL
- Analyzing Viatris (VTRS) as a Potential Contrarian Investment | 2025-02-28 | PHARMACEUTICAL
- Is Viatris (VTRS) Undervalued? Exploring Its Rating Status | 2025-02-27 | PHARMACEUTICAL
- Viatris Announces Cash Tender Offers for Senior Notes | 2024-09-04 | PHARMACEUTICAL
- VTRS Bucks Yearly Trend, Surges Upwards Today. | 2023-10-24 | MEDICINAL CHEMICALS
- Shares of Viatris Underperform the Market. What Do the Numbers Tell Us? | 2023-09-06 | MEDICINAL CHEMICALS
- Viatris Inc. (VTRS) — Undervalued With Excellent Growth Indicators | 2023-04-17 | MEDICINAL CHEMICALS
- What Are the Fundamentals of Viatris (VTRS)? | 2023-04-05 | MEDICINAL CHEMICALS
- Quick Look at Viatris (VTRS) | 2022-11-07 | DRUG MANUFACTURERS—SPECIALTY & GENERIC